Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.

Julian MüllerKarin NentwichArtur BerkovitzElena EneKai SonneIvaylo ChakarovSebastian BarthChristian WaechterUlrich LüsebrinkMichael BehnesIbrahim AkinThomas Deneke

Published in: Journal of cardiovascular electrophysiology (2022)

HPSD AF ablation of patients >75 years in experienced centers is safe and effective. Therefore, age alone should not be the reason to withhold AF ablation from vital elderly patients due to only a slightly worse outcome and safety profile. In paroxysmal AF, elderly patients have more recurrences compared to the younger control group.

Keyphrases

atrial fibrillation
catheter ablation
left atrial
oral anticoagulants
left atrial appendage
direct oral anticoagulants
end stage renal disease
newly diagnosed
heart failure
ejection fraction
percutaneous coronary intervention
radiofrequency ablation
left ventricular
patient reported outcomes